BIO 2024German Exhibitors Ningaloo Biosystems
Ningaloo Biosystems
Booth number: 4315-02
ningaloo.bio
About us
At Ningaloo Biosystems, we want to make sure that the next generation of medicines will be available and affordable for all patients who need them. We are going to help pharmaceutical companies to produce the latest biologics much more cost-effectively and at better quality. How? By using cyber-biological real-time control technology we can boost bioreactor performance. As an industry-experienced team, we are on our way to making Ningaloo the leading enabler of sustainable manufacturing of biologics.
Address
Ningaloo Biosystems
Gottfried-Hagen-Str. 60 – 62
51105 Cologne
Germany
Phone: +49 173 7278789
Gottfried-Hagen-Str. 60 – 62
51105 Cologne
Germany
Phone: +49 173 7278789
Ningaloo Biosystems
Gottfried-Hagen-Strasse 60-62
Cologne
Germany
Phone: +491737278789
Internet: https://ningaloo.bio
Gottfried-Hagen-Strasse 60-62
Cologne
Germany
Phone: +491737278789
Internet: https://ningaloo.bio
Contact person:
Herbert Mueller-Hartmann
Co-Founder & Managing Director
E-mail: h.mueller-hartmann@ningaloo.bio
Phone: +49 173 7278789
Products & Services
We provide cyber-bioproduction technology to boost output and quality of biopharmaceutical APIs in upstream processing. We also offer services to customize expression systems and create bespoke cyber-bioproduction host cell lines.Our products combine photoswitches with optical technology as a platform to introduce dynamic controls into bioproduction processes to address the most pressing challenges in biopharmaceutical production. Using this approach, we can e.g. optimize output of multi-component biopharmaceuticals, such as multi-specific antibodies or a gene therapeutic in real-time. The platform can be scaled with the systems used from process development to large scale production to enable automation and the expanded adoption of continuous production modes.
MultiLight MLA
The MultiLight MLA provides the platform for high-throughput optimization of cell culture-based processes using cyber-bioproduction for product yield and quality. It can also be used to produce active substances on a small scale. Working with multi-well plate formats and small cell culture vessels, it allows you to propel early process development for complex biopharmaceuticals to the next level of productivity.
